Effipride MV 1mg/500mg/0.2mg Tablet SR
Marketer
Efficus Life Sciences And Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Effipride MV 1mg/500mg/0.2mg Tablet SR
Diapride-MX 1mg/500mg/0.2mg extended-release tablets are classified as antidiabetic agents. This combination medication treats type 2 diabetes in adults by helping regulate blood glucose. Diapride-MX should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan incorporating a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular meals and carry a quick-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or breastfeeding individuals require medical consultation. Regular blood glucose monitoring and blood tests (to assess blood cell counts and liver function) may be recommended by your physician.
Uses of Effipride MV 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Effipride MV 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Effipride MV 1mg/500mg/0.2mg Tablet SR on an empty stomach.
Common Side effects of Effipride MV 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Effipride MV 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Effipride MV 1mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Effipride MV 1mg/500mg/0.2mg Tablet SR works:
Each Effipride MV SR tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Effipride MV 1mg/500mg/0.2mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Effipride MV 1mg/500mg/0.2mg Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against the risks before prescribing this medication. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release combination tablet, Effipride MV 1mg/500mg/0.2mg SR, is likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience such symptoms.
KidneyUNSAFE
The use of Effipride MV 1mg/500mg/0.2mg sustained-release tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is contraindicated in patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver disease should use Effipride MV 1mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dose modification. Consult a physician. For those with mild to moderate liver impairment, initiation should be at a low dose; it's contraindicated in severe liver disease.
What if you forget to take Effipride MV 1mg/500mg/0.2mg Tablet SR :
Should you forget to take your Effipride MV 1mg/500mg/0.2mg Tablet SR, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Effipride MV 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently